Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Cellular differentiation wikipedia , lookup
Extracellular matrix wikipedia , lookup
Cell growth wikipedia , lookup
Tissue engineering wikipedia , lookup
Cytokinesis wikipedia , lookup
Cell culture wikipedia , lookup
Organ-on-a-chip wikipedia , lookup
Cell encapsulation wikipedia , lookup
Cell membrane wikipedia , lookup
Nanocristalline zeolite scaffolds preparation for cancer cell adhesion, viability and drug treatment P. Tavolaro1, S. Catalano2, G. Martino3 and A. Tavolaro2 1 University of Calabria, Department of Pharmacy, Health and Nutritional Sciences, I-87036 Rende (CS), Italy 2 Research Institute on Membrane Technology, National Research Council of Italy, ITM-CNR, c/o University of Calabria, Via Bucci cubo 17/c, I-87036 Rende, Italy 3 University of Calabria, Department Di.B.E.S.T. (Biologia, Ecologia, Scienze della Terra), Unit of Physiology, Cubo 4/c, 87036, Rende, Italy [email protected] Abstract Zeolites due to their low toxicity and high compatibility are considered new biomaterials for medical applications and they can be used in different conformation as pure and hybrid membranes. Their growing applicability is connected with the presence of cavities and channels in structures, which allow to the chemical species guests to flow interacting with molecules and organic structures [1-3] as well as with non-modify human cells [4-5] together with the possibility to change framework, hydrophilicity, crystal size, chemical composition, acid-base characteristics and surface morphology. Our research it was directed to prepare N-Sil-1 and G-Sil-2 pure and hybrid zeolite membranes with different percentage of zeolite crystals (5%, 35%, 70%, 80%) and polylactic acid polymer. We have selected the MDA-MB-231 human breast cancer cell line as a model tumor cell line since breast cancer is the most common neoplastic disease [6]. Since doxorubicin (DOX) is a naturally occurring anthracycline antibiotic which is an essential component of many treatment regimens for solid and blood tumors, and it is broadly considered the most active single agent available for the treatment of breast cancer [7], we have treated MDA-MB-231 with DOX (4µg/mL) in order to assess the influence of zeolites on cell growth, proliferation and metastatic activity. All pure and hybrid zeolite membranes by were characterized scanning electron microscopy (FESEM), infrared spectrophotometry (FT-IR and FTIR ATR), X-ray diffraction (XRD), atomic force microscopy (AFM), Point of Zero Charge (PZC) and contact angle analyses. MDA-MB-231 cells were cultured with a density of 1x105 cell/ml. Scanning electron microscopy (FESEM) analysis has evidenced various morphology changes of the cells attached on various zeolite membranes as a result of the different chemical-physics properties and structural features of the synthesized scaffolds. In particular, the cells take squeezing globe-shaped if are grown on N-Sil-1 zeolite membranes while take polymorphic shape on G-Sil-2 pure zeolite membranes. MTT tests indicated that MDA-MB-231 cell viability is better on mixed matrix membranes respect to pure zeolite membranes. The results evidence that DOX inhibits cell viability of MDA-MB-231 grown on all zeolite membranes and MTT test shows that pure zeolite membranes are more responsive with respect to hybrid scaffolds and that N-Sil-1 is more responsive with respect to G-Sil-2. References [1] [2] [3] [4] Tavolaro, E. Drioli, Advanced Materials, 12 (1999) 975. Tavolaro, P. Tavolaro, E. Drioli, Colloid Surface B, 55, (2007) 67. Tavolaro, P. Tavolaro, G. Martino, Colloid Surface B, 70, (2009) 98. Tavolaro, P. Tavolaro, G. Martino, Membrana zeolitica per adesioni e colture di cellule, IT Patent CS2010A000003 (2010). [5] Tavolaro, G. Martino, P. Tavolaro, Zeolite membrane for cellular adhesion, growth and cultures and process for preparation thereof. PCT/EP2011/051915, 1095553 (2011). [6] J. Ferlay, H.-R. Shin, F. Bray, D. Forman, C. Mathers, D.M. Parkin, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008, Int. J. Cancer, 127 (2010) 2893. [7] K.Villman, J. Sjostrom, R. Heikkila, R. Hultborn, P. Malmstrom, N.O. Bengtsson, M. Soderberg, E. Saksela, C. Blomqvist, Acta Oncol., 45, (2006) 590.